Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong
Chris Ka Pun Mok, Carolyn A Cohen, Samuel M.S. Cheng, Chunke Chen, Kin-On Kwok, Karen Yiu, Tat-On Chan, Maireid Bull, Kwun Cheung Ling, Zixi Dai, Susanna S Ng, Grace Chung-Yan Lui, Chao Wu, Gaya K. Amerasinghe, Daisy W Leung, Samuel Yeung Shan Wong, Sophie A Valkenburg, Malik Peiris, David S Hui
doi: https://doi.org/10.1101/2021.10.28.21265635
Chris Ka Pun Mok
1The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, PR China
2Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, PR China
Carolyn A Cohen
3HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Samuel M.S. Cheng
4School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Chunke Chen
1The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, PR China
2Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, PR China
Kin-On Kwok
1The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, PR China
Karen Yiu
5Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, PR China
Tat-On Chan
5Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, PR China
Maireid Bull
3HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Kwun Cheung Ling
5Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, PR China
Zixi Dai
3HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Susanna S Ng
5Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, PR China
Grace Chung-Yan Lui
5Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, PR China
6Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
Chao Wu
7Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
Gaya K. Amerasinghe
7Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
Daisy W Leung
8Department of Internal Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
Samuel Yeung Shan Wong
1The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, PR China
Sophie A Valkenburg
3HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Malik Peiris
3HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
4School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
David S Hui
5Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, PR China
6Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
Article usage
Posted October 30, 2021.
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong
Chris Ka Pun Mok, Carolyn A Cohen, Samuel M.S. Cheng, Chunke Chen, Kin-On Kwok, Karen Yiu, Tat-On Chan, Maireid Bull, Kwun Cheung Ling, Zixi Dai, Susanna S Ng, Grace Chung-Yan Lui, Chao Wu, Gaya K. Amerasinghe, Daisy W Leung, Samuel Yeung Shan Wong, Sophie A Valkenburg, Malik Peiris, David S Hui
medRxiv 2021.10.28.21265635; doi: https://doi.org/10.1101/2021.10.28.21265635
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong
Chris Ka Pun Mok, Carolyn A Cohen, Samuel M.S. Cheng, Chunke Chen, Kin-On Kwok, Karen Yiu, Tat-On Chan, Maireid Bull, Kwun Cheung Ling, Zixi Dai, Susanna S Ng, Grace Chung-Yan Lui, Chao Wu, Gaya K. Amerasinghe, Daisy W Leung, Samuel Yeung Shan Wong, Sophie A Valkenburg, Malik Peiris, David S Hui
medRxiv 2021.10.28.21265635; doi: https://doi.org/10.1101/2021.10.28.21265635
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)